Endometrial Adenocarcinoma
Showing NaN - NaN of 6
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Active, not recruiting
- Endometrial Adenocarcinoma
- +9 more
- Bevacizumab
- +5 more
-
Phoenix, Arizona
- +232 more
Jan 12, 2023
Endometrial Cancer, Endometrial Adenocarcinoma Trial in United States (Pembrolizumab, Paclitaxel, Carboplatin)
Completed
- Endometrial Cancer
- Endometrial Adenocarcinoma
- Pembrolizumab
- +2 more
-
Mesa, Arizona
- +5 more
Feb 17, 2022
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +3 more
- Diagnostic Laboratory Biomarker Analysis
- Selumetinib
-
Los Angeles, California
- +71 more
Jul 19, 2019
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Canada, Hong
Completed
- Endometrial Adenocarcinoma
- +11 more
- Bevacizumab
- +4 more
-
Berkeley, California
- +40 more
Feb 15, 2018
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +8 more
- Brivanib Alaninate
- Laboratory Biomarker Analysis
-
Aurora, Colorado
- +34 more
Nov 2, 2017
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +8 more
-
Burbank, California
- +58 more
Sep 8, 2017